Autonomous biomedical research with an artificial intelligence agent
Researchers present Biomni, a general-purpose biomedical AI agent capable of autonomously executing diverse research tasks across fragmented workflows that traditionally slow scientific discovery. The system, published in Science, maps and orchestrates multi-step biomedical research pipelines without continuous human supervision. While not specifically designed for oncology, the platform has broad applicability to cancer research including drug discovery, biomarker analysis, and literature synthesis.
This summary was generated by AI (Claude Opus 5) from the source linked above and verified editorially — it may contain errors; the original source takes precedence.